The social reality of depression: Dtc advertising of antidepressants and perceptions of the prevalence and lifetime risk of depression [Book Review]
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Business Ethics 79 (4):379 - 393 (2008)
This study is rooted in the research traditions of cultivation theory, construct accessibility, and availability heuristic. Based on a survey with 221 subjects, this study finds that familiarity with direct-to-consumer (DTC) print advertisements for antidepressant brands is associated with inflated perceptions of the prevalence and lifetime risk of depression. The study concludes that DTC advertising potentially has significant effects on perceptions of depression prevalence and risk. Interpersonal experiences with depression coupled with DTC advertising appear to significantly predict individuals’ perceived lifetime risk of depression. The study ultimately demonstrates that DTC advertising may play a role in constructing social reality of diseases and medicine. The findings strongly suggest that the social cognitive effects of DTC advertising are far-reaching, impacting pharmaceutical marketing strategy as well as presenting issues regarding public health and the business ethics of advertising drugs to consumers.
|Keywords||antidepressants availability heuristic cultivation direct-to-consumer advertising perceived prevalence and risk of depression public policy regulation|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Hyunsoo Park, Michael F. Weigold & Debbie M. Treise (1999). Advertising Ethics: South Korean and American Perceptions and Ideology. Journal of Mass Media Ethics 14 (2):95 – 106.
Fred K. Beard (2003). College Student Attitudes Toward Advertising's Ethical, Economic, and Social Consequences. Journal of Business Ethics 48 (3):217-228.
George Graham (1990). Melancholic Epistemology. Synthese 82 (3):399-422.
Peter Lurie (2009). DTC Advertising Harms Patients and Should Be Tightly Regulated. Journal of Law, Medicine and Ethics 37 (3):444-450.
Ashish Chandra & Gary A. Holt (1999). Pharmaceutical Advertisements: How They Deceive Patients. [REVIEW] Journal of Business Ethics 18 (4):359 - 366.
Ker-Tah Hsu (2012). The Advertising Effects of Corporate Social Responsibility on Corporate Reputation and Brand Equity: Evidence From the Life Insurance Industry in Taiwan. [REVIEW] Journal of Business Ethics 109 (2):189-201.
Cornelius B. Pratt & E. Lincoln James (1994). Advertising Ethics: A Contextual Response Based on Classical Ethical Theory. [REVIEW] Journal of Business Ethics 13 (6):455 - 468.
Penny M. Simpson, Gene Brown & Robert E. Widing (1998). The Association of Ethical Judgment of Advertising and Selected Advertising Effectiveness Response Variables. Journal of Business Ethics 17 (2):125-136.
Paula Gardner (2003). Distorted Packaging: Marketing Depression as Illness, Drugs as Cure. Journal of Medical Humanities 24 (1/2):105-130.
Richard F. Beltramini (2006). Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs. Journal of Business Ethics 63 (4):333 - 343.
Added to index2009-01-28
Total downloads18 ( #76,894 of 1,006,187 )
Recent downloads (6 months)1 ( #64,735 of 1,006,187 )
How can I increase my downloads?